皮膚剥離症治療薬のグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Cutaneous Fribrosis Treatment Market Insights and Forecast to 2028

• レポートコード：QY2203B13371 • 出版社/出版日：QYResearch / 2022年3月 • レポート形態：英文、PDF、89ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥686,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,029,000 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,372,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

新型コロナウイルス感染症のパンデミックにより、世界の皮膚剥離症治療薬の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に皮膚剥離症治療薬の世界市場のxxx％を占める「副腎皮質ホルモン剤」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院薬局」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国の皮膚剥離症治療薬の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの皮膚剥離症治療薬市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの皮膚剥離症治療薬市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 皮膚剥離症治療薬のグローバル主要メーカーには、Pfizer、Sanofi、F. Hoffmann-La Roche、Boehringer Ingelheim、Jubilant Cadista、Horizon Pharma USA、Bristol-Myers Squibb Companyなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 皮膚剥離症治療薬市場は、種類と用途によって区分されます。世界の皮膚剥離症治療薬市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 副腎皮質ホルモン剤、抗線維化剤、免疫療法剤、その他 【用途別セグメント】 病院薬局、小売店薬局、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 皮膚剥離症治療薬製品概要 - 種類別市場（副腎皮質ホルモン剤、抗線維化剤、免疫療法剤、その他） - 用途別市場（病院薬局、小売店薬局、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の皮膚剥離症治療薬販売量予測2017-2028 - 世界の皮膚剥離症治療薬売上予測2017-2028 - 皮膚剥離症治療薬の地域別販売量 - 皮膚剥離症治療薬の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別皮膚剥離症治療薬販売量 - 主要メーカー別皮膚剥離症治療薬売上 - 主要メーカー別皮膚剥離症治療薬価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（副腎皮質ホルモン剤、抗線維化剤、免疫療法剤、その他） - 皮膚剥離症治療薬の種類別販売量 - 皮膚剥離症治療薬の種類別売上 - 皮膚剥離症治療薬の種類別価格 ・用途別市場規模（病院薬局、小売店薬局、その他） - 皮膚剥離症治療薬の用途別販売量 - 皮膚剥離症治療薬の用途別売上 - 皮膚剥離症治療薬の用途別価格 ・北米市場 - 北米の皮膚剥離症治療薬市場規模（種類別、用途別） - 主要国別の皮膚剥離症治療薬市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの皮膚剥離症治療薬市場規模（種類別、用途別） - 主要国別の皮膚剥離症治療薬市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の皮膚剥離症治療薬市場規模（種類別、用途別） - 主要国別の皮膚剥離症治療薬市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の皮膚剥離症治療薬市場規模（種類別、用途別） - 主要国別の皮膚剥離症治療薬市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの皮膚剥離症治療薬市場規模（種類別、用途別） - 主要国別の皮膚剥離症治療薬市場規模（トルコ、サウジアラビア） ・企業情報 Pfizer、Sanofi、F. Hoffmann-La Roche、Boehringer Ingelheim、Jubilant Cadista、Horizon Pharma USA、Bristol-Myers Squibb Company ・産業チェーン及び販売チャネル分析 - 皮膚剥離症治療薬の産業チェーン分析 - 皮膚剥離症治療薬の原材料 - 皮膚剥離症治療薬の生産プロセス - 皮膚剥離症治療薬の販売及びマーケティング - 皮膚剥離症治療薬の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 皮膚剥離症治療薬の産業動向 - 皮膚剥離症治療薬のマーケットドライバー - 皮膚剥離症治療薬の課題 - 皮膚剥離症治療薬の阻害要因 ・主な調査結果

Cutaneous Fribrosis Treatment refers to the treatment of skin myelofibrosis by drugs such as corticosteroids, anti-fibrotic drugs, and immunotherapy drugs.
Market Analysis and Insights: Global Cutaneous Fribrosis Treatment Market
Due to the COVID-19 pandemic, the global Cutaneous Fribrosis Treatment market size is estimated to be worth US$ 609.2 million in 2022 and is forecast to a readjusted size of US$ 868.1 million by 2028 with a CAGR of 6.1% during the review period. Fully considering the economic change by this health crisis, Corticosteroids accounting for % of the Cutaneous Fribrosis Treatment global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospital Pharmacy segment is altered to an % CAGR throughout this forecast period.
China Cutaneous Fribrosis Treatment market size is valued at US$ million in 2021, while the US and Europe Cutaneous Fribrosis Treatment are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Cutaneous Fribrosis Treatment landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Cutaneous Fribrosis Treatment include Pfizer, Sanofi, F. Hoffmann-La Roche, Boehringer Ingelheim, Jubilant Cadista, Horizon Pharma USA and Bristol-Myers Squibb Company, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Cutaneous Fribrosis Treatment Scope and Segment
Cutaneous Fribrosis Treatment market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Cutaneous Fribrosis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Corticosteroids
Antifibrotic Drugs
Immunotherapy Drugs
Other
Segment by Application
Hospital Pharmacy
Retail Pharmacy
Other
By Company
Pfizer
Sanofi
F. Hoffmann-La Roche
Boehringer Ingelheim
Jubilant Cadista
Horizon Pharma USA
Bristol-Myers Squibb Company
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

レポート目次

---

1 Study Coverage
1.1 Cutaneous Fribrosis Treatment Product Introduction
1.2 Market by Type
1.2.1 Global Cutaneous Fribrosis Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Corticosteroids
1.2.3 Antifibrotic Drugs
1.2.4 Immunotherapy Drugs
1.2.5 Other
1.3 Market by Application
1.3.1 Global Cutaneous Fribrosis Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Cutaneous Fribrosis Treatment Sales Estimates and Forecasts 2017-2028
2.2 Global Cutaneous Fribrosis Treatment Revenue Estimates and Forecasts 2017-2028
2.3 Global Cutaneous Fribrosis Treatment Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Cutaneous Fribrosis Treatment Sales by Region
2.4.1 Global Cutaneous Fribrosis Treatment Sales by Region (2017-2022)
2.4.2 Global Sales Cutaneous Fribrosis Treatment by Region (2023-2028)
2.5 Global Cutaneous Fribrosis Treatment Revenue by Region
2.5.1 Global Cutaneous Fribrosis Treatment Revenue by Region (2017-2022)
2.5.2 Global Cutaneous Fribrosis Treatment Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Cutaneous Fribrosis Treatment Sales by Manufacturers
3.1.1 Global Top Cutaneous Fribrosis Treatment Manufacturers by Sales (2017-2022)
3.1.2 Global Cutaneous Fribrosis Treatment Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Cutaneous Fribrosis Treatment in 2021
3.2 Global Cutaneous Fribrosis Treatment Revenue by Manufacturers
3.2.1 Global Cutaneous Fribrosis Treatment Revenue by Manufacturers (2017-2022)
3.2.2 Global Cutaneous Fribrosis Treatment Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Cutaneous Fribrosis Treatment Revenue in 2021
3.3 Global Cutaneous Fribrosis Treatment Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Cutaneous Fribrosis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Cutaneous Fribrosis Treatment Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Cutaneous Fribrosis Treatment Sales by Type
4.1.1 Global Cutaneous Fribrosis Treatment Historical Sales by Type (2017-2022)
4.1.2 Global Cutaneous Fribrosis Treatment Forecasted Sales by Type (2023-2028)
4.1.3 Global Cutaneous Fribrosis Treatment Sales Market Share by Type (2017-2028)
4.2 Global Cutaneous Fribrosis Treatment Revenue by Type
4.2.1 Global Cutaneous Fribrosis Treatment Historical Revenue by Type (2017-2022)
4.2.2 Global Cutaneous Fribrosis Treatment Forecasted Revenue by Type (2023-2028)
4.2.3 Global Cutaneous Fribrosis Treatment Revenue Market Share by Type (2017-2028)
4.3 Global Cutaneous Fribrosis Treatment Price by Type
4.3.1 Global Cutaneous Fribrosis Treatment Price by Type (2017-2022)
4.3.2 Global Cutaneous Fribrosis Treatment Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Cutaneous Fribrosis Treatment Sales by Application
5.1.1 Global Cutaneous Fribrosis Treatment Historical Sales by Application (2017-2022)
5.1.2 Global Cutaneous Fribrosis Treatment Forecasted Sales by Application (2023-2028)
5.1.3 Global Cutaneous Fribrosis Treatment Sales Market Share by Application (2017-2028)
5.2 Global Cutaneous Fribrosis Treatment Revenue by Application
5.2.1 Global Cutaneous Fribrosis Treatment Historical Revenue by Application (2017-2022)
5.2.2 Global Cutaneous Fribrosis Treatment Forecasted Revenue by Application (2023-2028)
5.2.3 Global Cutaneous Fribrosis Treatment Revenue Market Share by Application (2017-2028)
5.3 Global Cutaneous Fribrosis Treatment Price by Application
5.3.1 Global Cutaneous Fribrosis Treatment Price by Application (2017-2022)
5.3.2 Global Cutaneous Fribrosis Treatment Price Forecast by Application (2023-2028)
6 North America
6.1 North America Cutaneous Fribrosis Treatment Market Size by Type
6.1.1 North America Cutaneous Fribrosis Treatment Sales by Type (2017-2028)
6.1.2 North America Cutaneous Fribrosis Treatment Revenue by Type (2017-2028)
6.2 North America Cutaneous Fribrosis Treatment Market Size by Application
6.2.1 North America Cutaneous Fribrosis Treatment Sales by Application (2017-2028)
6.2.2 North America Cutaneous Fribrosis Treatment Revenue by Application (2017-2028)
6.3 North America Cutaneous Fribrosis Treatment Market Size by Country
6.3.1 North America Cutaneous Fribrosis Treatment Sales by Country (2017-2028)
6.3.2 North America Cutaneous Fribrosis Treatment Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Cutaneous Fribrosis Treatment Market Size by Type
7.1.1 Europe Cutaneous Fribrosis Treatment Sales by Type (2017-2028)
7.1.2 Europe Cutaneous Fribrosis Treatment Revenue by Type (2017-2028)
7.2 Europe Cutaneous Fribrosis Treatment Market Size by Application
7.2.1 Europe Cutaneous Fribrosis Treatment Sales by Application (2017-2028)
7.2.2 Europe Cutaneous Fribrosis Treatment Revenue by Application (2017-2028)
7.3 Europe Cutaneous Fribrosis Treatment Market Size by Country
7.3.1 Europe Cutaneous Fribrosis Treatment Sales by Country (2017-2028)
7.3.2 Europe Cutaneous Fribrosis Treatment Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Cutaneous Fribrosis Treatment Market Size by Type
8.1.1 Asia Pacific Cutaneous Fribrosis Treatment Sales by Type (2017-2028)
8.1.2 Asia Pacific Cutaneous Fribrosis Treatment Revenue by Type (2017-2028)
8.2 Asia Pacific Cutaneous Fribrosis Treatment Market Size by Application
8.2.1 Asia Pacific Cutaneous Fribrosis Treatment Sales by Application (2017-2028)
8.2.2 Asia Pacific Cutaneous Fribrosis Treatment Revenue by Application (2017-2028)
8.3 Asia Pacific Cutaneous Fribrosis Treatment Market Size by Region
8.3.1 Asia Pacific Cutaneous Fribrosis Treatment Sales by Region (2017-2028)
8.3.2 Asia Pacific Cutaneous Fribrosis Treatment Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Cutaneous Fribrosis Treatment Market Size by Type
9.1.1 Latin America Cutaneous Fribrosis Treatment Sales by Type (2017-2028)
9.1.2 Latin America Cutaneous Fribrosis Treatment Revenue by Type (2017-2028)
9.2 Latin America Cutaneous Fribrosis Treatment Market Size by Application
9.2.1 Latin America Cutaneous Fribrosis Treatment Sales by Application (2017-2028)
9.2.2 Latin America Cutaneous Fribrosis Treatment Revenue by Application (2017-2028)
9.3 Latin America Cutaneous Fribrosis Treatment Market Size by Country
9.3.1 Latin America Cutaneous Fribrosis Treatment Sales by Country (2017-2028)
9.3.2 Latin America Cutaneous Fribrosis Treatment Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Cutaneous Fribrosis Treatment Market Size by Type
10.1.1 Middle East and Africa Cutaneous Fribrosis Treatment Sales by Type (2017-2028)
10.1.2 Middle East and Africa Cutaneous Fribrosis Treatment Revenue by Type (2017-2028)
10.2 Middle East and Africa Cutaneous Fribrosis Treatment Market Size by Application
10.2.1 Middle East and Africa Cutaneous Fribrosis Treatment Sales by Application (2017-2028)
10.2.2 Middle East and Africa Cutaneous Fribrosis Treatment Revenue by Application (2017-2028)
10.3 Middle East and Africa Cutaneous Fribrosis Treatment Market Size by Country
10.3.1 Middle East and Africa Cutaneous Fribrosis Treatment Sales by Country (2017-2028)
10.3.2 Middle East and Africa Cutaneous Fribrosis Treatment Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Overview
11.1.3 Pfizer Cutaneous Fribrosis Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Pfizer Cutaneous Fribrosis Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Pfizer Recent Developments
11.2 Sanofi
11.2.1 Sanofi Corporation Information
11.2.2 Sanofi Overview
11.2.3 Sanofi Cutaneous Fribrosis Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Sanofi Cutaneous Fribrosis Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Sanofi Recent Developments
11.3 F. Hoffmann-La Roche
11.3.1 F. Hoffmann-La Roche Corporation Information
11.3.2 F. Hoffmann-La Roche Overview
11.3.3 F. Hoffmann-La Roche Cutaneous Fribrosis Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 F. Hoffmann-La Roche Cutaneous Fribrosis Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 F. Hoffmann-La Roche Recent Developments
11.4 Boehringer Ingelheim
11.4.1 Boehringer Ingelheim Corporation Information
11.4.2 Boehringer Ingelheim Overview
11.4.3 Boehringer Ingelheim Cutaneous Fribrosis Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Boehringer Ingelheim Cutaneous Fribrosis Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Boehringer Ingelheim Recent Developments
11.5 Jubilant Cadista
11.5.1 Jubilant Cadista Corporation Information
11.5.2 Jubilant Cadista Overview
11.5.3 Jubilant Cadista Cutaneous Fribrosis Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Jubilant Cadista Cutaneous Fribrosis Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Jubilant Cadista Recent Developments
11.6 Horizon Pharma USA
11.6.1 Horizon Pharma USA Corporation Information
11.6.2 Horizon Pharma USA Overview
11.6.3 Horizon Pharma USA Cutaneous Fribrosis Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Horizon Pharma USA Cutaneous Fribrosis Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Horizon Pharma USA Recent Developments
11.7 Bristol-Myers Squibb Company
11.7.1 Bristol-Myers Squibb Company Corporation Information
11.7.2 Bristol-Myers Squibb Company Overview
11.7.3 Bristol-Myers Squibb Company Cutaneous Fribrosis Treatment Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Bristol-Myers Squibb Company Cutaneous Fribrosis Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Bristol-Myers Squibb Company Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Cutaneous Fribrosis Treatment Industry Chain Analysis
12.2 Cutaneous Fribrosis Treatment Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Cutaneous Fribrosis Treatment Production Mode & Process
12.4 Cutaneous Fribrosis Treatment Sales and Marketing
12.4.1 Cutaneous Fribrosis Treatment Sales Channels
12.4.2 Cutaneous Fribrosis Treatment Distributors
12.5 Cutaneous Fribrosis Treatment Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Cutaneous Fribrosis Treatment Industry Trends
13.2 Cutaneous Fribrosis Treatment Market Drivers
13.3 Cutaneous Fribrosis Treatment Market Challenges
13.4 Cutaneous Fribrosis Treatment Market Restraints
14 Key Findings in The Global Cutaneous Fribrosis Treatment Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Cutaneous Fribrosis Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Corticosteroids
Table 3. Major Manufacturers of Antifibrotic Drugs
Table 4. Major Manufacturers of Immunotherapy Drugs
Table 5. Major Manufacturers of Other
Table 6. Global Cutaneous Fribrosis Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Cutaneous Fribrosis Treatment Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Cutaneous Fribrosis Treatment Sales by Region (2017-2022) & (MT)
Table 9. Global Cutaneous Fribrosis Treatment Sales Market Share by Region (2017-2022)
Table 10. Global Cutaneous Fribrosis Treatment Sales by Region (2023-2028) & (MT)
Table 11. Global Cutaneous Fribrosis Treatment Sales Market Share by Region (2023-2028)
Table 12. Global Cutaneous Fribrosis Treatment Revenue by Region (2017-2022) & (US$ Million)
Table 13. Global Cutaneous Fribrosis Treatment Revenue Market Share by Region (2017-2022)
Table 14. Global Cutaneous Fribrosis Treatment Revenue by Region (2023-2028) & (US$ Million)
Table 15. Global Cutaneous Fribrosis Treatment Revenue Market Share by Region (2023-2028)
Table 16. Global Cutaneous Fribrosis Treatment Sales by Manufacturers (2017-2022) & (MT)
Table 17. Global Cutaneous Fribrosis Treatment Sales Share by Manufacturers (2017-2022)
Table 18. Global Cutaneous Fribrosis Treatment Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 19. Global Cutaneous Fribrosis Treatment Revenue Share by Manufacturers (2017-2022)
Table 20. Cutaneous Fribrosis Treatment Price by Manufacturers (2017-2022) &(USD/MT)
Table 21. Global Cutaneous Fribrosis Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Cutaneous Fribrosis Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cutaneous Fribrosis Treatment as of 2021)
Table 23. Cutaneous Fribrosis Treatment Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Cutaneous Fribrosis Treatment Product Offered
Table 25. Date of Manufacturers Enter into Cutaneous Fribrosis Treatment Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Cutaneous Fribrosis Treatment Sales by Type (2017-2022) & (MT)
Table 28. Global Cutaneous Fribrosis Treatment Sales by Type (2023-2028) & (MT)
Table 29. Global Cutaneous Fribrosis Treatment Sales Share by Type (2017-2022)
Table 30. Global Cutaneous Fribrosis Treatment Sales Share by Type (2023-2028)
Table 31. Global Cutaneous Fribrosis Treatment Revenue by Type (2017-2022) & (US$ Million)
Table 32. Global Cutaneous Fribrosis Treatment Revenue by Type (2023-2028) & (US$ Million)
Table 33. Global Cutaneous Fribrosis Treatment Revenue Share by Type (2017-2022)
Table 34. Global Cutaneous Fribrosis Treatment Revenue Share by Type (2023-2028)
Table 35. Cutaneous Fribrosis Treatment Price by Type (2017-2022) & (USD/MT)
Table 36. Global Cutaneous Fribrosis Treatment Price Forecast by Type (2023-2028) & (USD/MT)
Table 37. Global Cutaneous Fribrosis Treatment Sales by Application (2017-2022) & (MT)
Table 38. Global Cutaneous Fribrosis Treatment Sales by Application (2023-2028) & (MT)
Table 39. Global Cutaneous Fribrosis Treatment Sales Share by Application (2017-2022)
Table 40. Global Cutaneous Fribrosis Treatment Sales Share by Application (2023-2028)
Table 41. Global Cutaneous Fribrosis Treatment Revenue by Application (2017-2022) & (US$ Million)
Table 42. Global Cutaneous Fribrosis Treatment Revenue by Application (2023-2028) & (US$ Million)
Table 43. Global Cutaneous Fribrosis Treatment Revenue Share by Application (2017-2022)
Table 44. Global Cutaneous Fribrosis Treatment Revenue Share by Application (2023-2028)
Table 45. Cutaneous Fribrosis Treatment Price by Application (2017-2022) & (USD/MT)
Table 46. Global Cutaneous Fribrosis Treatment Price Forecast by Application (2023-2028) & (USD/MT)
Table 47. North America Cutaneous Fribrosis Treatment Sales by Type (2017-2022) & (MT)
Table 48. North America Cutaneous Fribrosis Treatment Sales by Type (2023-2028) & (MT)
Table 49. North America Cutaneous Fribrosis Treatment Revenue by Type (2017-2022) & (US$ Million)
Table 50. North America Cutaneous Fribrosis Treatment Revenue by Type (2023-2028) & (US$ Million)
Table 51. North America Cutaneous Fribrosis Treatment Sales by Application (2017-2022) & (MT)
Table 52. North America Cutaneous Fribrosis Treatment Sales by Application (2023-2028) & (MT)
Table 53. North America Cutaneous Fribrosis Treatment Revenue by Application (2017-2022) & (US$ Million)
Table 54. North America Cutaneous Fribrosis Treatment Revenue by Application (2023-2028) & (US$ Million)
Table 55. North America Cutaneous Fribrosis Treatment Sales by Country (2017-2022) & (MT)
Table 56. North America Cutaneous Fribrosis Treatment Sales by Country (2023-2028) & (MT)
Table 57. North America Cutaneous Fribrosis Treatment Revenue by Country (2017-2022) & (US$ Million)
Table 58. North America Cutaneous Fribrosis Treatment Revenue by Country (2023-2028) & (US$ Million)
Table 59. Europe Cutaneous Fribrosis Treatment Sales by Type (2017-2022) & (MT)
Table 60. Europe Cutaneous Fribrosis Treatment Sales by Type (2023-2028) & (MT)
Table 61. Europe Cutaneous Fribrosis Treatment Revenue by Type (2017-2022) & (US$ Million)
Table 62. Europe Cutaneous Fribrosis Treatment Revenue by Type (2023-2028) & (US$ Million)
Table 63. Europe Cutaneous Fribrosis Treatment Sales by Application (2017-2022) & (MT)
Table 64. Europe Cutaneous Fribrosis Treatment Sales by Application (2023-2028) & (MT)
Table 65. Europe Cutaneous Fribrosis Treatment Revenue by Application (2017-2022) & (US$ Million)
Table 66. Europe Cutaneous Fribrosis Treatment Revenue by Application (2023-2028) & (US$ Million)
Table 67. Europe Cutaneous Fribrosis Treatment Sales by Country (2017-2022) & (MT)
Table 68. Europe Cutaneous Fribrosis Treatment Sales by Country (2023-2028) & (MT)
Table 69. Europe Cutaneous Fribrosis Treatment Revenue by Country (2017-2022) & (US$ Million)
Table 70. Europe Cutaneous Fribrosis Treatment Revenue by Country (2023-2028) & (US$ Million)
Table 71. Asia Pacific Cutaneous Fribrosis Treatment Sales by Type (2017-2022) & (MT)
Table 72. Asia Pacific Cutaneous Fribrosis Treatment Sales by Type (2023-2028) & (MT)
Table 73. Asia Pacific Cutaneous Fribrosis Treatment Revenue by Type (2017-2022) & (US$ Million)
Table 74. Asia Pacific Cutaneous Fribrosis Treatment Revenue by Type (2023-2028) & (US$ Million)
Table 75. Asia Pacific Cutaneous Fribrosis Treatment Sales by Application (2017-2022) & (MT)
Table 76. Asia Pacific Cutaneous Fribrosis Treatment Sales by Application (2023-2028) & (MT)
Table 77. Asia Pacific Cutaneous Fribrosis Treatment Revenue by Application (2017-2022) & (US$ Million)
Table 78. Asia Pacific Cutaneous Fribrosis Treatment Revenue by Application (2023-2028) & (US$ Million)
Table 79. Asia Pacific Cutaneous Fribrosis Treatment Sales by Region (2017-2022) & (MT)
Table 80. Asia Pacific Cutaneous Fribrosis Treatment Sales by Region (2023-2028) & (MT)
Table 81. Asia Pacific Cutaneous Fribrosis Treatment Revenue by Region (2017-2022) & (US$ Million)
Table 82. Asia Pacific Cutaneous Fribrosis Treatment Revenue by Region (2023-2028) & (US$ Million)
Table 83. Latin America Cutaneous Fribrosis Treatment Sales by Type (2017-2022) & (MT)
Table 84. Latin America Cutaneous Fribrosis Treatment Sales by Type (2023-2028) & (MT)
Table 85. Latin America Cutaneous Fribrosis Treatment Revenue by Type (2017-2022) & (US$ Million)
Table 86. Latin America Cutaneous Fribrosis Treatment Revenue by Type (2023-2028) & (US$ Million)
Table 87. Latin America Cutaneous Fribrosis Treatment Sales by Application (2017-2022) & (MT)
Table 88. Latin America Cutaneous Fribrosis Treatment Sales by Application (2023-2028) & (MT)
Table 89. Latin America Cutaneous Fribrosis Treatment Revenue by Application (2017-2022) & (US$ Million)
Table 90. Latin America Cutaneous Fribrosis Treatment Revenue by Application (2023-2028) & (US$ Million)
Table 91. Latin America Cutaneous Fribrosis Treatment Sales by Country (2017-2022) & (MT)
Table 92. Latin America Cutaneous Fribrosis Treatment Sales by Country (2023-2028) & (MT)
Table 93. Latin America Cutaneous Fribrosis Treatment Revenue by Country (2017-2022) & (US$ Million)
Table 94. Latin America Cutaneous Fribrosis Treatment Revenue by Country (2023-2028) & (US$ Million)
Table 95. Middle East and Africa Cutaneous Fribrosis Treatment Sales by Type (2017-2022) & (MT)
Table 96. Middle East and Africa Cutaneous Fribrosis Treatment Sales by Type (2023-2028) & (MT)
Table 97. Middle East and Africa Cutaneous Fribrosis Treatment Revenue by Type (2017-2022) & (US$ Million)
Table 98. Middle East and Africa Cutaneous Fribrosis Treatment Revenue by Type (2023-2028) & (US$ Million)
Table 99. Middle East and Africa Cutaneous Fribrosis Treatment Sales by Application (2017-2022) & (MT)
Table 100. Middle East and Africa Cutaneous Fribrosis Treatment Sales by Application (2023-2028) & (MT)
Table 101. Middle East and Africa Cutaneous Fribrosis Treatment Revenue by Application (2017-2022) & (US$ Million)
Table 102. Middle East and Africa Cutaneous Fribrosis Treatment Revenue by Application (2023-2028) & (US$ Million)
Table 103. Middle East and Africa Cutaneous Fribrosis Treatment Sales by Country (2017-2022) & (MT)
Table 104. Middle East and Africa Cutaneous Fribrosis Treatment Sales by Country (2023-2028) & (MT)
Table 105. Middle East and Africa Cutaneous Fribrosis Treatment Revenue by Country (2017-2022) & (US$ Million)
Table 106. Middle East and Africa Cutaneous Fribrosis Treatment Revenue by Country (2023-2028) & (US$ Million)
Table 107. Pfizer Corporation Information
Table 108. Pfizer Description and Major Businesses
Table 109. Pfizer Cutaneous Fribrosis Treatment Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 110. Pfizer Cutaneous Fribrosis Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Pfizer Recent Developments
Table 112. Sanofi Corporation Information
Table 113. Sanofi Description and Major Businesses
Table 114. Sanofi Cutaneous Fribrosis Treatment Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 115. Sanofi Cutaneous Fribrosis Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Sanofi Recent Developments
Table 117. F. Hoffmann-La Roche Corporation Information
Table 118. F. Hoffmann-La Roche Description and Major Businesses
Table 119. F. Hoffmann-La Roche Cutaneous Fribrosis Treatment Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 120. F. Hoffmann-La Roche Cutaneous Fribrosis Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. F. Hoffmann-La Roche Recent Developments
Table 122. Boehringer Ingelheim Corporation Information
Table 123. Boehringer Ingelheim Description and Major Businesses
Table 124. Boehringer Ingelheim Cutaneous Fribrosis Treatment Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 125. Boehringer Ingelheim Cutaneous Fribrosis Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Boehringer Ingelheim Recent Developments
Table 127. Jubilant Cadista Corporation Information
Table 128. Jubilant Cadista Description and Major Businesses
Table 129. Jubilant Cadista Cutaneous Fribrosis Treatment Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 130. Jubilant Cadista Cutaneous Fribrosis Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Jubilant Cadista Recent Developments
Table 132. Horizon Pharma USA Corporation Information
Table 133. Horizon Pharma USA Description and Major Businesses
Table 134. Horizon Pharma USA Cutaneous Fribrosis Treatment Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 135. Horizon Pharma USA Cutaneous Fribrosis Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Horizon Pharma USA Recent Developments
Table 137. Bristol-Myers Squibb Company Corporation Information
Table 138. Bristol-Myers Squibb Company Description and Major Businesses
Table 139. Bristol-Myers Squibb Company Cutaneous Fribrosis Treatment Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 140. Bristol-Myers Squibb Company Cutaneous Fribrosis Treatment Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Bristol-Myers Squibb Company Recent Developments
Table 142. Key Raw Materials Lists
Table 143. Raw Materials Key Suppliers Lists
Table 144. Cutaneous Fribrosis Treatment Distributors List
Table 145. Cutaneous Fribrosis Treatment Customers List
Table 146. Cutaneous Fribrosis Treatment Market Trends
Table 147. Cutaneous Fribrosis Treatment Market Drivers
Table 148. Cutaneous Fribrosis Treatment Market Challenges
Table 149. Cutaneous Fribrosis Treatment Market Restraints
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
List of Figures
Figure 1. Cutaneous Fribrosis Treatment Product Picture
Figure 3. Global Cutaneous Fribrosis Treatment Market Share by Type in 2021 & 2028
Figure 3. Corticosteroids Product Picture
Figure 4. Antifibrotic Drugs Product Picture
Figure 5. Immunotherapy Drugs Product Picture
Figure 6. Other Product Picture
Figure 7. Global Cutaneous Fribrosis Treatment Market Share by Application in 2021 & 2028
Figure 8. Hospital Pharmacy
Figure 9. Retail Pharmacy
Figure 10. Other
Figure 11. Cutaneous Fribrosis Treatment Report Years Considered
Figure 12. Global Cutaneous Fribrosis Treatment Sales 2017-2028 (MT)
Figure 13. Global Cutaneous Fribrosis Treatment Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Cutaneous Fribrosis Treatment Revenue 2017-2028 (US$ Million)
Figure 15. Global Cutaneous Fribrosis Treatment Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 16. Global Cutaneous Fribrosis Treatment Sales Market Share by Region (2017-2022)
Figure 17. Global Cutaneous Fribrosis Treatment Sales Market Share by Region (2023-2028)
Figure 18. North America Cutaneous Fribrosis Treatment Sales YoY (2017-2028) & (MT)
Figure 19. North America Cutaneous Fribrosis Treatment Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Europe Cutaneous Fribrosis Treatment Sales YoY (2017-2028) & (MT)
Figure 21. Europe Cutaneous Fribrosis Treatment Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Asia-Pacific Cutaneous Fribrosis Treatment Sales YoY (2017-2028) & (MT)
Figure 23. Asia-Pacific Cutaneous Fribrosis Treatment Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Latin America Cutaneous Fribrosis Treatment Sales YoY (2017-2028) & (MT)
Figure 25. Latin America Cutaneous Fribrosis Treatment Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Middle East & Africa Cutaneous Fribrosis Treatment Sales YoY (2017-2028) & (MT)
Figure 27. Middle East & Africa Cutaneous Fribrosis Treatment Revenue YoY (2017-2028) & (US$ Million)
Figure 28. The Cutaneous Fribrosis Treatment Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 29. The Top 5 and 10 Largest Manufacturers of Cutaneous Fribrosis Treatment in the World: Market Share by Cutaneous Fribrosis Treatment Revenue in 2021
Figure 30. Global Cutaneous Fribrosis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 31. Global Cutaneous Fribrosis Treatment Sales Market Share by Type (2017-2028)
Figure 32. Global Cutaneous Fribrosis Treatment Revenue Market Share by Type (2017-2028)
Figure 33. Global Cutaneous Fribrosis Treatment Sales Market Share by Application (2017-2028)
Figure 34. Global Cutaneous Fribrosis Treatment Revenue Market Share by Application (2017-2028)
Figure 35. North America Cutaneous Fribrosis Treatment Sales Market Share by Type (2017-2028)
Figure 36. North America Cutaneous Fribrosis Treatment Revenue Market Share by Type (2017-2028)
Figure 37. North America Cutaneous Fribrosis Treatment Sales Market Share by Application (2017-2028)
Figure 38. North America Cutaneous Fribrosis Treatment Revenue Market Share by Application (2017-2028)
Figure 39. North America Cutaneous Fribrosis Treatment Sales Share by Country (2017-2028)
Figure 40. North America Cutaneous Fribrosis Treatment Revenue Share by Country (2017-2028)
Figure 41. U.S. Cutaneous Fribrosis Treatment Revenue (2017-2028) & (US$ Million)
Figure 42. Canada Cutaneous Fribrosis Treatment Revenue (2017-2028) & (US$ Million)
Figure 43. Europe Cutaneous Fribrosis Treatment Sales Market Share by Type (2017-2028)
Figure 44. Europe Cutaneous Fribrosis Treatment Revenue Market Share by Type (2017-2028)
Figure 45. Europe Cutaneous Fribrosis Treatment Sales Market Share by Application (2017-2028)
Figure 46. Europe Cutaneous Fribrosis Treatment Revenue Market Share by Application (2017-2028)
Figure 47. Europe Cutaneous Fribrosis Treatment Sales Share by Country (2017-2028)
Figure 48. Europe Cutaneous Fribrosis Treatment Revenue Share by Country (2017-2028)
Figure 49. Germany Cutaneous Fribrosis Treatment Revenue (2017-2028) & (US$ Million)
Figure 50. France Cutaneous Fribrosis Treatment Revenue (2017-2028) & (US$ Million)
Figure 51. U.K. Cutaneous Fribrosis Treatment Revenue (2017-2028) & (US$ Million)
Figure 52. Italy Cutaneous Fribrosis Treatment Revenue (2017-2028) & (US$ Million)
Figure 53. Russia Cutaneous Fribrosis Treatment Revenue (2017-2028) & (US$ Million)
Figure 54. Asia Pacific Cutaneous Fribrosis Treatment Sales Market Share by Type (2017-2028)
Figure 55. Asia Pacific Cutaneous Fribrosis Treatment Revenue Market Share by Type (2017-2028)
Figure 56. Asia Pacific Cutaneous Fribrosis Treatment Sales Market Share by Application (2017-2028)
Figure 57. Asia Pacific Cutaneous Fribrosis Treatment Revenue Market Share by Application (2017-2028)
Figure 58. Asia Pacific Cutaneous Fribrosis Treatment Sales Share by Region (2017-2028)
Figure 59. Asia Pacific Cutaneous Fribrosis Treatment Revenue Share by Region (2017-2028)
Figure 60. China Cutaneous Fribrosis Treatment Revenue (2017-2028) & (US$ Million)
Figure 61. Japan Cutaneous Fribrosis Treatment Revenue (2017-2028) & (US$ Million)
Figure 62. South Korea Cutaneous Fribrosis Treatment Revenue (2017-2028) & (US$ Million)
Figure 63. India Cutaneous Fribrosis Treatment Revenue (2017-2028) & (US$ Million)
Figure 64. Australia Cutaneous Fribrosis Treatment Revenue (2017-2028) & (US$ Million)
Figure 65. Taiwan Cutaneous Fribrosis Treatment Revenue (2017-2028) & (US$ Million)
Figure 66. Indonesia Cutaneous Fribrosis Treatment Revenue (2017-2028) & (US$ Million)
Figure 67. Thailand Cutaneous Fribrosis Treatment Revenue (2017-2028) & (US$ Million)
Figure 68. Malaysia Cutaneous Fribrosis Treatment Revenue (2017-2028) & (US$ Million)
Figure 69. Philippines Cutaneous Fribrosis Treatment Revenue (2017-2028) & (US$ Million)
Figure 70. Latin America Cutaneous Fribrosis Treatment Sales Market Share by Type (2017-2028)
Figure 71. Latin America Cutaneous Fribrosis Treatment Revenue Market Share by Type (2017-2028)
Figure 72. Latin America Cutaneous Fribrosis Treatment Sales Market Share by Application (2017-2028)
Figure 73. Latin America Cutaneous Fribrosis Treatment Revenue Market Share by Application (2017-2028)
Figure 74. Latin America Cutaneous Fribrosis Treatment Sales Share by Country (2017-2028)
Figure 75. Latin America Cutaneous Fribrosis Treatment Revenue Share by Country (2017-2028)
Figure 76. Mexico Cutaneous Fribrosis Treatment Revenue (2017-2028) & (US$ Million)
Figure 77. Brazil Cutaneous Fribrosis Treatment Revenue (2017-2028) & (US$ Million)
Figure 78. Argentina Cutaneous Fribrosis Treatment Revenue (2017-2028) & (US$ Million)
Figure 79. Middle East and Africa Cutaneous Fribrosis Treatment Sales Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Cutaneous Fribrosis Treatment Revenue Market Share by Type (2017-2028)
Figure 81. Middle East and Africa Cutaneous Fribrosis Treatment Sales Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Cutaneous Fribrosis Treatment Revenue Market Share by Application (2017-2028)
Figure 83. Middle East and Africa Cutaneous Fribrosis Treatment Sales Share by Country (2017-2028)
Figure 84. Middle East and Africa Cutaneous Fribrosis Treatment Revenue Share by Country (2017-2028)
Figure 85. Turkey Cutaneous Fribrosis Treatment Revenue (2017-2028) & (US$ Million)
Figure 86. Saudi Arabia Cutaneous Fribrosis Treatment Revenue (2017-2028) & (US$ Million)
Figure 87. U.A.E Cutaneous Fribrosis Treatment Revenue (2017-2028) & (US$ Million)
Figure 88. Cutaneous Fribrosis Treatment Value Chain
Figure 89. Cutaneous Fribrosis Treatment Production Process
Figure 90. Channels of Distribution
Figure 91. Distributors Profiles
Figure 92. Bottom-up and Top-down Approaches for This Report
Figure 93. Data Triangulation
Figure 94. Key Executives Interviewed

---